For Better Health
Askdocweb is about side effects
Search for
Home star Site Map star Resources star Contact Us star Privacy Policy star Advertise
 

About Curaderm-BEC5

We are collecting comments and product reviews about Curaderm-BEC5.

What is Curaderm-BEC5?

Curaderm-BEC5 is advertised as a clinically proven, cost-effective treatment for both primary and secondary non-melanoma skin cancer care. Dr Cham has published articles claiming a cure for several skin cancers using extracts from a common garden plant.

New Hope for Those with Skin Cancer

Is CuradermBEC5 the best answer for the treatment of Skin Cancer? Curaderm-BEC5 cream is a new topical treatment developed by Brisbane scientist Dr Bill Cham whose cosmetic outcome appears far superior to current treatment methods.
Dermatologists at Royal London Hospital and nine other United Kingdom skin cancer treatment centers have supported claims that Curaderm-BEC cures skin cancer and is a viable alternative to conventional surgery, chemotherapy and laser treatments.

Dermatologists applied the topical cream twice daily to the cancer lesion and within weeks, laboratory biopsies confirmed the BEC cream eliminated all traces of cancer. This startling discovery is a major medical breakthrough, as skin cancer is quickly becoming a health epidemic.

Skin cancer management usually involves surgery, and the risks of surgical intervention are well known. Excision of skin cancer (cutting it out), such as a Basal Cell Carcinoma (BCC), from the facial area often involves reconstructive surgery, which can be both time consuming and costly.

Dr. Sangeeta Punjabl of the Royal London Hospital concluded the Curaderm-BEC evaluation by stating, "We consider that this rate of treatment success more than justifies the physician considering BEC as an alternative to currently predominant treatment such as surgical excision or cryotherapy."

Clinically Proven Skin Cancer Treatment

Curaderm-BEC5 is a blended cream, available in a 20ml application vial containing 0.005% mixture of Solasodine Glycosides. Solasodine Glycosides are from the same family of active constituents that also occurs naturally in Eggplant. The native Australian plant called "Devils Apple" is specifically cultivated for Curaderm-BEC5 skin cancer treatment. Australia's aboriginal people have used the Devils Apple plant for its curative powers for thousands of years. The ancient aboriginals used the plant to treat ulcers. Dr Bill Cham researched this natural cure and identified the plant's active constituents. The patented Curaderm-BEC5 treatment now incorporates the active constituents extracted from the "Devils Apple" and purified to enhance their curative powers.

Eliminate non-melanoma skin cancers deep below the skin and destroy only the cancer cells. Healthy cells are not harmed and new skin growth replaces the cancer cells with no scaring.

Curaderm is a medicine used to treat areas of the skin, which may have been discolored, thickened or scaly as a result of exposure to sun (UV) light. Curaderm has a clinically proven 80- 100% success rate across all pre-cancerous and non-melanoma Skin cancers such as keratoses, sun spots, basal cell carcinoma, and squamous cell carcinoma.

Curaderm-BEC5 is available in a 20ml application vial. The application vial contains enough cream to treat one or two large skin cancers, six average ones or a dozen sunspots for about $99 and the price includes delivery.

History of Curaderm

The brand Curaderm was originally manufactured and distributed by Cura Nominees Pty LTD in Australia. This followed full clinical trials and monitoring of participants beyond five years. The brand was immediately popular as an over the counter medicine in Australia. Over 60,000 units of Curaderm were sold in the first few weeks of release of the product.

The rapid popularization of the effective treatment lead to a lobby movement by the Australian Dermatologists and Skin cancer surgeons. The lobbying efforts lead to Curaderm to becoming re-classified to prescription only status. This action severely affected the brands reach, however, sales and excellent treatment results continued throughout the 1990's. Cura's restricted Curaderm sales were balanced by the company manufacturing other successful cosmetic and therapeutic products for the Australian market.

Dr. Cham was disappointed with the Australian medical system reclassifying Curaderm so that information on Curaderm was hidden from the consumer. By 2000, a double blind randomized vehicle controlled clinical trial with leading United Kingdom Dermatologists and Hospitals was arranged. A primary objective of this trial was to prove the treatment to be a safe home based treatment. The excellent results paralleled results from clinical trials in Queensland during the 1980's and completely refuted all wrongful statements suggested by the Australian Dermatology lobby.

Despite this irrefutable evidence, Curaderm was not given any praise by the Australian dermatologists about the United Kingdom clinical results. Even the Australian Medical Journal was not cooperative to publish the excellent results so the Australian doctors could be more informed and prescribe the treatment to consumers.

With Curaderm in such a restrictive position within the Australian market it was decided the entire brand including manufacturing, management and distribution would be moved out of Australia.

After ten years of painstaking research, Dr Cham who works at the Queensland Department of Medicine, developed Curaderm cream. He claims the cream has virtually a 100% success rate in curing skin cancer and has been internationally patented. With Curaderm, Dr Cham has had to overcome many challenges to get the product to marketplace.

Curaderm has been acknowledged worldwide as a breakthrough in treating skin cancers and until recently was sold over the counter, but health authorities have placed in on prescription only. Dr Cham says he discovered the curative powers of the Devil apple plant and kangaroo Apple from a veterinarian at the University who told him Aborigines used the juices to stop eye cancer. But he said the biggest breakthrough and the most exciting part to the research is that the active ingredients used to treat skin cancer have killed internal cancer in mice.

He claims cancer introduced into mice has been killed and the mice lived a full life span. He has also tested it on human cancer cells and the treatment has killed them without harming normal human cells.

Dr Cham says as soon as pharmacology has been completed, the treatment will be tested on cancer patients.

In further research, Dr Cham and his team are in the final stages of testing a treatment that flushes cholesterol out of the body.

Heart disease is the biggest killer in the world and they have developed a treatment that not only flushes cholesterol from the blood but also from the arteries as well.

He said while current treatments can lower cholesterol levels in the blood, they have not been able to remove it from clogged arteries.

If all the tests prove positive this treatment will hopefully be available to the public within five years. Tests begin at the Wesley Hospital, Brisbane, this year.

To finance his research, Dr Cham has developed and made available to all Australians a unique range of medicated and skin care products made in Australia specifically for Australians. The products marketed as 'Curacel' are based on the same principles as his effective skin cancer research, that to be truly effective products must penetrate the skin.

Curacel has products that treat arthritic pain, sunspots, eczema, dermatitis, psoriasis, acne, pimples, herpes, warts, sunburn and cold sores. Curacel also markets a range of skin care derived from Dr Cham's research.

The Curacel skin care formula has come to the attention of the major French cosmetic companies who have made lucrative offers to buy the formula, however Dr Cham is not selling. The products will remain Australian made.

Excerpts from Heritage 2000's display at the Queensland Times Home and Leisure Show.

EXTRACTS from a common garden weed may hold the key to a cure for skin cancer.

After 10 years of painstaking research, Brisbane scientist Bill Cham, who works at the University Of Queensland Department Of Medicine, has developed Curaderm privately. He claims the cream has virtually 100 per cent success rate in curing skin cancer, and has been internationally patented.

With Curaderm Dr Cham has had to overcome many challenges to have the product accepted by the marketplace.

Dr Cham said Curaderm had been acknowledged world-wide as a breakthrough in treating skin cancer and until recently had been sold over the counter, but health authorities had now placed it on prescription only.

He said he had discovered the curative powers of the Devil Apple plant and Kangaroo Apple from a veterinarian at the university who had told him that Aborigines used the juices to stop eye cancer.

However, Dr Cham said the biggest breakthrough and the most exciting part of the research was that the anti-skin cancer ingredient had been tested in human cancer cells and the treatment had killed them without harming normal human cells. Dr Cham said that as soon as pharmacology had been completed the treatment would be tested on cancer patients.

To finance his research Dr Cham has developed a range of medicated and skin care products. The products, marketed as Curacel, are based on the same principles as his skin cancer research, that to be truly effective products must penetrate the skin.

The Curacel medicated range has treatments for arthritic pain, sunspots, eczema, acne, pimples, warts, sunburn and cold sores.

The skin care range includes soap free cleansers, moisturizers, scrubs, masks and a non greasy sunscreen, aluminum-free deodorants and two new products, the Colour Complexion Cream and Direct Skin Peel.

DR SKIN

Who is this man they call "Dr Skin"? Dr Bill Cham is a humble genius with a humanitarian heart. His quest to find a cure for skin cancer seems to have been rewarded. He has now been acknowledged worldwide for his breakthrough in the skin cancer treatment 'Curaderm'.

An internationally patented cream Curaderm has enabled patients to fully recover from severe skin cancers eliminating suffering and avoiding inevitable death.

THE DEVIL'S APPLE

In this quest to find a cancer cure Dr Cham tested the Devil's apple plant, commonly regarded as a weed on the eastern seaboard of Australia. The results were astonishing and in time Dr Cham has developed an extract that was highly effective in the treatment of cancerous cells. After 10 years of painstaking research and development "Curaderm" was launched as a cure for skin cancer.

"That was only half the problem," recalls Dr Cham, "that's merely dealing with live cancer cells in a Petrie dish. The next stage was just as difficult. The skin on the flesh grows from the inside out and is constantly being shed. You might think of it as a ... of cells flowing upward. To get the cancer treatment down to the forming cells where it is required, you must attach it to a substance which allows you to penetrate deep against that current."

In his search for a penetrating cream that would perform that task, Dr Cham tested over 60 moisturizing creams currently available on the market. In all case he found the claim of the manufactures to be at best, exaggerated, and at worse, fallacious. Another problem stemmed from the wide use of soap acids as a base for these products. Cancerous skin is sensitive skin, and stearates can irritate, thereby exacerbating the problem.

"Finally I decided to develop my own moisturizing cream. I used a unique form of mucopolysaccharides. These are naturally occurring water and oil-binding agents which have the ability to take ingredients into the skin to nourish it at the level skin cells are born. That essentially solved the problem. I had the bomb, then the delivery system, the result was we could literally explode the cancer cells, destroying them for good."

Curaderm is a cream extracted from a plant called the Devils Apple Fruit or Solanum sodomaeum. The active ingredient in Curaderm is Solasodine Glycosides (0.005%) is also found in smaller quantities in the eggplant and aubergine. Since 1982, the active has been shown to be effective in the treatment of the malignant human skin tumors. In 2002 an evaluation study by Ten United Kingdom Hospitals there is now a worldwide clinically approved skin cancer cream available that has advantages over conventional methods

Curaderm BEC5 cream has also been shown to be efficacious with benign tumors, including Keratoses, Keratoa canthomas, Sun spots, and age spots.

WELCOME TO THE CURA HOUSE OF HOPE

It would seem that the tireless Dr Cham is locked into a do or die endurance test to relieve the human race of much of its ailments. His accomplishments to date seem impossible for one man to have achieved in only a few decades and with limited research funds and facilities available to him. But hold onto your hats and consider this impressive list of treatments that he has now made available through his distribution company. The intense research which led to the development of Curaderm and an effective treatment for skin cancer has created a phenomenal range of spin off cures and relieving treatments that have until now caused widespread suffering and discomfort.

These include an impressive range of products for the following conditions: Acne and Blemished skins, Eczema, Dermatitis and Psoriasis, Herpes including genital herpes, genital warts and even chicken pox as well as products to relieve Arthritis and Sporting injuries.

Income derived from the sale of these unique products contributes to Dr Cham's ongoing internal cancer research...a successful treatment for which Bill Cham believes is quote, "Not far off" unquote (You heard it here first).

I guess because big American company has not developed it, it has not had the funds to make inroads into USA market.

It has been developed privately and against resistance from surgeons who have a vested interest in current treatments.

It is an affordable accessible treatment that undermines a large industry of surgery and laser treatment.

There is also the fear factor that prompts people to take the quick fix even at the higher cost.

As it is so non toxic and has such great results word is spreading. I'm not sure it is widely known, outside of Australia and parts of Great Britain. Developers of effective, non-toxic, and inexpensive cancer treatments get harassed, and worse. It's not in some powerful pharma's financial interests to have such treatments widely available.:-(

The Curaderm-BEC5 cream formula is based on scientific formulations developed through the 1980s and first released on the Australian market in 1990. The cream contains a standardized mixture of triglycosides, solasonine and solamargine and their corresponding di- and mono-glycosides (see publications).

CuradermBEC5 is a topical cream, which can be applied to areas infected with skin cancer destroying all cancerous cells without harming the healthy ones. It is a non-poisonous cream, which contains no harmful ingredients that can cause side effects.

CuradermBEC5 is natural as it is obtained from an active ingredient found in a fruit called "the devil's apple" The same ingredients are found in the foods we eat daily, such as eggplants, potatoes etc.

What is Curaderm BEC5 used for?

This medicine is used to treat areas if the skin that may have become discolored, thickened or scaly as a result of exposure to sun (UV) light. These areas of the skin are known as keratoses.

Curaderm-BEC5 is a clinically proven, cost-effective treatment for both primary and secondary skin cancer care. Each 20ml application vial of Curaderm-BEC5 that provides enough cream to treat one or two large skin cancers, six average ones or a dozen sunspots for US$115 including delivery.

This medicine is also been clinically shown to be very effective to treat malignant skin cancers such as the non-melanoma basal cell carcinoma (BCC) and squamous cell carcinoma (SCC).

Curaderm is a medicine used to treat areas of the skin, which may have been discolored, thickened or scaly as a result of exposure to sun (UV) light. Skin cancers such as keratoses, basal cell carcinoma, and squamous cell carcinoma and Non-melanoma's.

Clinical Trials of Curaderm

Numerous clinical trials in Australia and Great Britain have confirmed BEC5's ability to regress non-melanoma skin cancers. In one open study with 72 patients, treatment with BEC5 cream resulted in the regression of all treated lesions (56 actinic keratoses, 39 BCCs and 29 SCCs), with 100% healed after 1 to 13 weeks of treatment.

Recent trials in 10 UK hospitals found that a twice daily topical application of BEC5 cream to the affected areas gave a complete remission to 78% of the patients within 8-weeks. The remaining 22% of patients had also improved and needed longer treatment times; all this was made possible without chemotherapy, radiotherapy or surgery. The dermatologists at the Royal London Hospital concluded that: "BEC5 is a topical preparation which is safe and effective, an ideal therapy for outpatient treatment... It is a cost-effective treatment for both primary and secondary skin cancer care." Furthermore, the histological analyses of biopsies taken before, during and after treatment give compelling evidence of the continuing efficacy of BEC5 because treated skin cancer lesions have not recurred for at least 5 years after cessation of therapy. BEC5 cream is therefore recommended to be used to treat areas of the skin that may have become discolored, thickened or scaly as a result of exposure to sun (UV) light. These areas of the skin are known as keratoses. BEC5 cream is effective to treat true malignant skin cancers such as the non-melanoma basal cell carcinoma and squamous cell carcinoma.

To date, it is estimated that more than 80,000 people have used BEC5 and shown below are just some of the results achieved with BEC5 cream: BEC5 works because it contains a plant sugar called rhamnose, (which is not usually found in mammalian species). Specific endogenous lectins, (which are receptors for the sugar part of the glycoalkaloids) are present in the plasma membranes of susceptible cancer cells, but they not present in normal cells. Therefore BEC5 recognizes and binds the sugar rhamnose of the glycoalkaloid to the cancer cell. Subsequently, this enters the cancer cell and causes cell death by destroying the lysosome.

Side effects to date have been limited to skin reddening, although during treatment erosion, ulceration and shedding of unwanted skin cells is also likely to take place. Clean the area to be treated with a mild antiseptic to remove old skin cells. BEC5 should be applied relatively thickly to the area at least twice daily and a micro pore placed over the area.

Before using Curaderm-BEC5

Before you use BEC5 Tell your health professional if you have allergies to any other medicines, foods, preservatives or drugs. The anticancer ingredient BEC is present in eggplant, so if you are allergic to eggplant, let your health professional know before you use BEC5. Do not use this medicine if you are allergic to aspirin.

Not to be used on children under 12 years without doctor's advice. BEC5 should be stored below 25 degrees C. Keep out of Reach of Children.

Areas being treated with BEC5 should remain covered with a dressing such as a micro pore. BEC5 should not be applied to moles or melanomas. How to use BEC5 Follow all information given by your health professional carefully. They may be slightly different from the information contained in this leaflet. If you do not understand the directions for use ask your health professional for help.

How to use BEC5

BEC5 is used only to treat external areas of the skin. The treatment areas may be characterized by swelling, thickening, redness or lesions.

Tell your health professional if you have allergies to any other medicines, foods, preservatives or drugs. The anticancer ingredient BEC is present in eggplant, so if you are allergic to eggplant, let your health professional know before you use BEC5. Do not use this medicine if you are allergic to aspirin.

Not to be used on children under 12 years without doctor's advice. BEC5 should be stored below 25 degrees C. Keep out of Reach of Children.

BEC5 should not be applied to moles or melanomas.

Care should be taken NOT to apply BEC5 cream to the unaffected areas. Areas near the eyes or lips should be treated very carefully.

What are the ingredients in Curaderm-BEC5?

Curaderm is a cream extracted from a plant called the Devils Apple Fruit (Solanum sodomaeum). The active ingredient in Curaderm is Solasodine Glycosides, commonly known as BEC5. It also contains Saliyclic Acid and Urea at a very high concentration.

Curaderm-BEC5 contains Salicylic Acid and Urea at high concentrations, which helps assist BEC5 to find and reach the cancer cells. Curaderm-BEC5 is a homogeneous cream formulation packaged in a 20ml application vial containing 0.005% mixture of Solasodine Glycosides. The active constituents are derived from a native Australian plant called "Devils Apple" which are specifically cultivated for Curaderm-BEC5 skin cancer treatment. These active constituents are extracted from the "Devils Apple" then purified to enhance their curative powers. Solasodine Glycosides are from the same family of active constituents that also occurs naturally in Eggplant, which is consumed in large volumes worldwide.

Curaderm-BEC5 is a standardized mixture of two triglycosides, Solasonine and Solamargine and their corresponding diglycosides and monoglycosides. Solasodine is a steroid alkaloid.

BEC5 cream (20g) contains the active anticancer ingredient Solasodine Glycosides (BEC). It also contains Salicyclic Acid and Urea at relatively high concentrations that assist BEC to kill cancer cells. Salicyclic Acid Urea may irritate the skin.

How does Curaderm-BEC5 work?

Solamargine is a naturally occurring solasodine triglycoside that binds to the EELs and this interaction initiates a chain of events, resulting in the internalization of solamargine with concomitant delivery of solasodine to the targeted cell. Solamargine travels via the desmosomes to the lysosomes. The action of solamargine is lysosomotropic (rupturing of the lysosome). This results in sudden death for the cancer cells.

Curaderm-BEC5 finds Keratosis and Sunspot cells in your skin by using specific cell receptors, which only allow the precancerous cells to be recognized. These cells are then destroyed and removed completely leaving the healthy skin cells unharmed.

The Salicylic Acid and Urea in Curaderm irritates the skin, which causes the skin to become red and inflamed. The redness and inflammation are signs that it is working and indicates that the active ingredients are penetrating your skin in order to trace the cancer cells.

Urea and salicylic acid are included in the cream as keratolytic. This enhances the penetration of Curaderm-BEC5 into the tumor and aids in the removal of dead tissues. Curaderm-BEC5 destroys non-Melanoma cancer cells without affecting the normal cells. It is a proven home based treatment, confirmed by the Royal London Hospital.

Cancer on the surface of the skin tissue is treated and the deep penetrating delivery cream then allows the active constituents to penetrate the skin and attack the whole cancer hidden beneath the skin tissue.

In simplified terms Curaderm-BEC5 seeks out and destroys cancerous cells leaving normal cells unaffected. Once Curaderm-BEC5 interacts with cancer cells, it invades the stomach (lysosome) of the cancer cells and causes the stomach to disintegrate, resulting in immediate death of the targeted cancer cells.

Curaderm-BEC5: the clinically proven, cost-effective treatment for both primary and secondary skin cancer care.

It is intended for twice daily application to the lesion until it is completely gone. (Research indicates that faster recovery is possible with more frequent daily applications)

CuradermBEC5 is applied to the infected area twice daily for up to eight weeks. The patient will experience minor pains during the first one or two days of application and from then on Curaderm will be doing its tasks of destroying the cancer cells. It will penetrate deep into the infected area destroying all cancer cells without causing any damage to the healthy cells and later helps regrowth of your new tissues. By the time your sore has been healed your skin will be back to normal, leaving little or no scar behind, and of course doing you a big, big favor by respecting your wallet.

How to use Curaderm BEC5

First cleanse the skin by applying a good antiseptic solution, massaging into the site and then rinsing clean under running water. This ensures removal of dead cells that might otherwise from a barrier against the penetration of BEC5.

Dry the site thoroughly, and then apply a thick layer of BEC5 across the treatment site. Cover with a dressing (micro pore). Wash hands after application.

How much BEC5 to use

Depending on the size of the area to be treated, between approximately 0.1 and 0.5g of cream may be required for each treatment. The total area of skin treated with BEC5 should not exceed 25cm squared at any one time. If larger areas require treatment extra care should be taken.

Care should be taken NOT to apply BEC5 cream to the unaffected areas. Areas near the eyes or lips should be treated very carefully. BEC5 should be used at least twice daily but may also be used up to ten times daily. It is important to always cover the treated area with dressing such as a micro pore. DO NOT let the area being treated dry out. The area should be treated until it has re-grown with new skin.

Before each application

First cleanse the skin by applying a good antiseptic solution, massaging into the site and then rinsing clean under running water. This ensures removal of dead cells that might otherwise from a barrier against the penetration of BEC5.

Dry the site thoroughly, and then apply a thick layer of BEC5 across the treatment site. Cover with a dressing (micro pore). Wash hands after application.

How much BEC5 to use

Depending on the size of the area to be treated, between approximately 0.1 and 0.5g of cream may be required for each treatment. The total area of skin treated with BEC5 should not exceed 25cm squared at any one time. If larger areas require treatment extra care should be taken.

The frequency of treatment varies with the size and location to be treated and individual sensitivity of skin. A minimum treatment is twice per day. Some people wanting rapid progress will do 7 times per day. Dr Cham suggests that you start with 2x and increase if you are comfortable with effects of treatment.

When the swelling in the area subsides and the treated skin appears normal, the treatment should be discontinued and the redness will gradually fade. On occasion it may be necessary to prolong the treatment regime. If in doubt it is better to treat the area for an extended period in order to prevent re-occurrence. In this case, the treatment should continue until such time as the lesion has re-grown with new tissue.

If you forget to use BEC5

It is important to ensure a regular treatment regime. Multiple skipped treatments may result in growth of normal skin over the top of the lesion. This can result in masking and thus the incomplete, treatment of the lesion. IF you inadvertently forget to use BEC5, you should recommence using BEC5 at least twice daily, or as originally directed.

If you use too much

Wipe away any excess and then wash BEC5 cream from the affected areas using soap and water.

The eyes should be avoided. If any excess occurs, wash and wipe away with cold water. Application should continue for a minimum of 7 days and a maximum of 60 days, this time dependant upon the size, need and regularity of application. BEC5 should not be applied to moles and melanomas. Furthermore, persons who are allergic to eggplant or aspirin should not use BEC5. For full details please see the approved use leaflet below. A 20-ml. bottle of BEC5 can provide enough material to treat one large skin cancer, two medium sized ones, six small ones or twelve sun spots. Apart from the need to treat cancer, BEC5's efficacy to help remove and protect against sun spots represents a major step forward in the prevention and "control" of skin cancers. Its ease of use, cost-effectiveness, proven efficacy and safety all represent a very significant breakthrough for majority of skin carcinomas, which are by far the most common forms of cancer.

Treatment with Curaderm BEC5 of Sunspots and Keratoses involves applying the cream 2 or 3 times a day and within a few days the skin will appear normal again.

What to expect

First reddening, as the active ingredients penetrates your skin will redden.

Then usually erosion - the cancer cells will die causing a dip in the skin tissue.

Ulceration - from the lesion you will notice some discharges of pus. That indicates the dead cancer cells are being recessed from the skin tissue.

Decline of the treated unwanted skin cells followed by re-growth of normal skin tissue - When the swelling in the area subsides and the treated skin appears normal, the treatment should be discontinued and the redness will gradually fade and you will know that your treatment with Curaderm-BEC5 is completed.

When BEC5 is used the following pattern of response can be anticipated. First reddening, then usually erosion, ulceration and decline of the treated unwanted skin cells followed by re-growth of normal skin tissue. During treatment the lesion may appear worse before treatment. This is because BEC seeks out and destroys the cancer cells that are not visible with the bare eyes.

In most cases some degree of redness and swelling will be observed during treatment. Tingling or some pain may be experienced for 30 to 60 minutes after each application, this is a normal reaction.

When BEC5 is used the following pattern of response can be anticipated. First reddening, then usually erosion, ulceration and decline of the treated unwanted skin cells followed by re-growth of normal skin tissue. During treatment the lesion may appear worse before treatment. This is because BEC seeks out and destroys the cancer cells that are not visible with the bare eyes.

The normal reactions seen when applying daily (at least twice) the Curaderm BEC5 to the lesion or affected areas are some degree of redness and swelling, tingling sensation or pain which can be experienced for 30-60 minutes.

The pattern of responses can be anticipated by: reddening, then usually erosion, ulceration and decline of the treated of the unwanted cells followed by the re-growth of the normal skin tissue. (Note: During treatment of the lesions may appear worse than before treatment. That is because BEC seeks and destroys the cancer cells that are non-visible to the naked eye)

When using Curaderm BEC5 there is no scar formation of skin tissue. You will not lose the re-growth of normal tissue. There is limited access to the cancer if it exists within the lesion if it is deep within the skin. And there is a low rate of the reoccurrence of the skin cancer.

How long does it take to work?

A usual treatment regime will last for 7 to 60 days, depending on the number of applications per day and on the individual's sensitivity. When the swelling in the area subsides and the treated skin appears normal, the treatment should be discontinued and the redness will gradually fade. On occasion it may be necessary to prolong the treatment regime. If in doubt it is better to treat the area for an extended period in order to prevent re-occurrence. In this case, the treatment should continue until such time as the lesion has re-grown with new tissue.

If you forget to use BEC5

It is important to ensure a regular treatment regime. Multiple skipped treatments may result in growth of normal skin over the top of the lesion. This can result in masking and thus the incomplete, treatment of the lesion. IF you inadvertently forget to use BEC5, you should recommence using BEC5 at least twice daily, or as originally directed. If you use too much, wipe away any excess and then wash BEC5 cream from the affected areas using soap and water.

Success rate

The general success rate of the glycoalkaloid (BEC) cream was 78 percent. Longer duration therapy with BEC would have resulted in higher success rates. These results were comparable to those previously obtained with Curaderm. Not only was it shown that this cream was effective in treating superficial BCC, but in a subsequent open study trial carried out at the Dermatology Department at the Royal London Hospital it was also shown that the glycoalkaloid cream was effective on morpheoic BCC lesions, which are a type of invasive BCC. The clinical trial experience has shown that the BEC was safe.

What side effects do users of Curaderm-BEC5 report?

If swelling, irritation, pain or redness is prolonged, distressing or excessive- seek your health professional's advice. If you experience any other effects that you believe may be associated with the use of this cream you should also discuss these symptoms with your health professional. Curaderm is non-toxic, non-mutagenic and does not affect the heartbeat or blood flow. Biochemical, hematological and URI analytical studies demonstrated that there were no adverse effects on the liver, kidneys or haematopoietic system (blood cells) during and after treatment.

When to discontinue Curaderm-BEC5 use

Treatment with Curaderm-BEC5 should only be stopped when the treated area has grown new skin tissue. Once there are no open wounds, small sores, little or no scaring and a new layer of skin covers the entire area where the skin cancer was then you can stop treatment. Do not stop the treatment prematurely as the skin cancer may grow back.

Side Effects

If swelling, irritation, pain or redness is prolonged, distressing or excessive- seek your health professional's advice. If you experience any other effects that you believe may be associated with the use of this cream you should also discuss these symptoms with your health professional.

History of Curaderm-BEC5

In 1979, Dr. Cham discovered the amazing effects of Glycoalkaloid in destroying skin cancer cells when he heard about a cow which remarkably stopped the growth of a skin cancer on it's eye by rubbing it against the leaf of a Devil's Apple Plant. The scientific name is S. sodomaneum L., also known as S. hermannii Dunal. It is native to South Africa and the Mediterranean basin. The Devil's Apple Plant was introduced to Australia in 1801.

Dr. Cham took samples of the Devil's Apple plant leaves for research and identified the Glycoalkaloid solasodine glycosides biochemical, known as BEC, and it's anticancer activity in cell culture, humans and animals. Dr. Cham continued studies and research of Glycoalkaloid throughout the 1980's, which made him the founder of Glycoalkaloid cancer research. From then on a whole new field of medical research of glycoalkaloid compounds and its potential for other beneficial uses such as well being, cancer and other specialized medications was discovered.

Dr. Cham has conducted human studies involving keratoses, basal cell carcinoma, squamous cell carcinomas and other skin lesions. All studies showed a regression of 100% of the skin lesions. Specifically, a Curaderm study was conducted. Dr. Cham patented the production process for his cream and continued his research for five years before he released the results. Many of his patients have been cancer-free for 10 years or more.

The cancer destroying capacities of Curaderm-BEC5 has been well documented by medical journals worldwide. Curaderm-BEC5 cream formula was discovered and invented by Dr. Cham, the founder of this natural compound with its amazing destruction capabilities.

During the development of Curaderm-BEC5, Dr Cham prime concern was always the safety of the human subjects.

Results time and time again are consistent that Curaderm and its active ingredient, BEC, when used according to the manufacturer instructions is completely safe.

Research into what is now known as Curaderm-BEC5 began in Australia in 1978 by world renowned Biochemist Dr. Bill Elliot Cham. Since then all stages of pharmaceutical development and clinical trials have proven the patented technology to be a true breakthrough for modern medicine. 100,000 people have now achieved excellent clinical results with biopsy confirmed zero presence of cancer cells. Curaderm-BEC5 has an exceptional safety record and no adverse reactions.

Current News on Curaderm-BEC5

Physicians and medical doctors at the ICIM Medical Conference (Kentucky, March 2007) have congratulated Dr. Bill Elliot Cham for his excellent and much needed medical breakthrough. Yes. There does exist a safe, non-toxic, non-surgical way to completely remove Sun spots/Keratoses, Basal cell and Squamous cell carcinoma. The cream technology absolutely removes skin cancer cells without affecting healthy skin tissue.

Dermatologists at Royal London Hospital (UK) agree that Curaderm-BEC5 is a safe an effective alternative to currently predominant treatments such as surgical excision or cryotherapy.

Safety of Curaderm-BEC5

CuradermBEC5 is safe and very effective; it is ideal for outpatient use. Leading UK hospitals including the Royal London Hospital concluded phase 3 clinical trials saying Curaderm is a cost-effective treatment, which can cure both primary and secondary skin cancer.

Biochemical, hematological and urinanalytical studies demonstrated that there were no adverse effects on the liver, kidneys or haematopoietic system (blood cells) during and after treatment.

You no longer have to be so worried about having your body exposed to the radiation associated with Chemo or Radiotherapy. Dr. Cham says that it is definitely the substitute for Chemotherapy and Radiotherapy.

Curaderm-BEC5 has undergone every possible safety test and the results have been made publicly available. Patients under some studies have undergone follow up tests for up to ten years following treatment assuring that no adverse reactions or recurrence are associated with Curaderm.

References

Kupchan, S. M., Barboutis, S. J., Knox, J. R. Lau Cam, C.A. (1065) Science 150, 1827-1828.
Kupchan, S. M. (1970) Trans. N.Y. Acad. Sci. 32, 85-86.
Cham B. E., Gilliver, M., Wilson, L. (1987) Planta Med. 34-46
Flora of Australia (1982) Bureau of Flora and Fauna, Canberra, Australian Government Publishing Services, Canberra, Australia, 29, p 162.
Briggs, L. H., Cambie. R. C., Hyslop, D. M. (1975) J. Chem. Soc. Perkins Trans. 1,2455-2457.
Briggs, L. H., Cambie. R. C., Hoare, J. L. (1963) J. Chem. Soc. 2848-2853.
Kuhn R., Low. I. (1947) Chem. Ber. 80, 406-410.
Waters Sourcebook for Chromatography (1985) sugar Analysis, p.39, Milford. M. A.
Briggs, L. H., Newbold, R. P., Stace N. E. (1942) J. Chem. Soc. 3-12.
Briggs, L. H., Cambie R. C. (1958) J. Chem. Soc. 1422-1425.
Hurst, E. (1942) The poisonous plants of New South Wales compiled under the direction of the poisonous plants committee of N.S.W., Sydney.
The Committee, p 352.
Kingsbury, J. M. (1964) Poinsonous plants of United States and Canada, Englewood Cliffs, NY. New York, Prentice Hall, p 275.

Curaderm Feedback

If you've used Curaderm, please help others by sharing your experience with side effects. What would you tell someone who was considering using this product?

Most recent post: March 6, 2014


The best support comes from understanding shared experiences. If you have used Curaderm, use the form below to add your review of Curaderm, feedback or suggestions. Please note that all email addresses are held confidential.

Thanks for stopping by.
AskDocWeb

Your name:
Your email:
Add your product review in the box below:

 

This consumer advocate website is protected by copyright 2008-2014 Askdocweb, Inc. All Rights Reserved. This is a layman's report on Curaderm-BEC and is not intended to replace discussions with a health care provider. Do not use the information on this forum as a substitute for your doctor's advice. Always consult your doctor before taking any drug and follow your doctor's directions. Askdocweb, Inc. may be paid a commission on products sold through links to other websites. For more information see FTC Disclaimer. Source material: Food and Drug Administration, Medline, Physician's Desk Reference, and the largest community of people in the world, those who are concerned about side effects and healthcare.
Bottom of page